Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Cardiology

Screening for stroke risk can save lives and money

Atrial fibrillation is the greatest risk factor for stroke. Screening to detect atrial fibrillation in older people would not only increase the chance of preventing stroke, it would also save money for the healthcare system ...

Medications

FDA says ADHD med Adderall is in short supply

People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.

Genetics

New clinical practice resource on hearing loss

The American College of Medical Genetics and Genomics (ACMG) has released a new Clinical Practice Resource that will help direct the treatment of patients with hearing loss. The guidelines were published in Genetics in Medicine.

page 2 from 19